Quality ManagementCommercialJanuary 22, 2025

Statin Therapy for Patients with Cardiovascular Disease (SPC) 2025

HEDIS® (Healthcare Effectiveness Data Information Set) is a widely used set of performance measures developed and maintained by NCQA. These are used to drive improvement efforts surrounding best practices.

HEDIS measure

This HEDIS measure looks at the percentage of males 21 to 75 years of age and females 40 to 75 years of age during the measurement year, who were identified as having clinical atherosclerotic cardiovascular disease (ASCVD) and met the following criteria.

Refer to attachments to view full details

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Commercial services provided by Anthem Blue Cross and Blue Shield, trade name of Anthem HealthChoice HMO, Inc. and Anthem HealthChoice Assurance, Inc., or Anthem Blue Cross and Blue Shield HP, trade name of Anthem HP, LLC.
Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BC-CM-075644-24-CPN74996, MULTI-BCBS-CM-075645-24-CPN74996

ATTACHMENTS: Statin Therapy for Patients with Cardiovascular Disease (SPC) 2025 - Blue Cross (pdf - 0.16mb), Statin Therapy for Patients with Cardiovascular Disease (SPC) 2025 - Blue Cross Blue Shield (pdf - 0.15mb)